The aim is to further document the safety and efficacy of Ketoconazole HRA administered in routine clinical practice in patients with CS.~The study operates under real clinical practice conditions, i.e. there is no treatment protocol thus.
This is a non-interventional, prospective, multinational, multicentre, observational study, in which data collected are those derived from routine clinical practice via an European registry on CS: ERCUSYN.